Ondřej Slanař - Search Results

Year	Number of Results
2005	1
2006	2
2007	1
2008	2
2009	3
2010	6
2011	2
2012	5
2013	3
2014	1
2015	2
2016	2
2017	8
2018	7
2019	11
2020	16
2021	15
2022	23
2023	18
2024	11

1

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives.

Hartinger JM, Kratky V, Hruskova Z, Slanar O, Tesar V. Hartinger JM, et al. Among authors: slanar o. Front Immunol. 2022 Nov 7;13:1024068. doi: 10.3389/fimmu.2022.1024068. eCollection 2022. Front Immunol. 2022. PMID: 36420256 Free PMC article. Review.

2

Pharmacokinetics of Dasatinib.

Hořínková J, Šíma M, Slanař O. Hořínková J, et al. Among authors: slanar o. Prague Med Rep. 2019;120(2-3):52-63. doi: 10.14712/23362936.2019.10. Prague Med Rep. 2019. PMID: 31586504 Free article. Review.

3

Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings.

Sklenárová M, Šíma M, Slanař O. Sklenárová M, et al. Among authors: slanar o. Prague Med Rep. 2023;124(3):216-229. doi: 10.14712/23362936.2023.17. Prague Med Rep. 2023. PMID: 37736946 Free article. Review.

4

Factors Affecting Drug Exposure after Inhalation.

Nováková A, Šíma M, Slanař O. Nováková A, et al. Among authors: slanar o. Prague Med Rep. 2022;123(3):129-139. doi: 10.14712/23362936.2022.13. Prague Med Rep. 2022. PMID: 36107443 Free article. Review.

5

Dose Optimization and Targeting Strategies of Anti-Infective Agents.

Šíma M, Slanař O. Šíma M, et al. Among authors: slanar o. Pharmaceutics. 2023 Jul 3;15(7):1870. doi: 10.3390/pharmaceutics15071870. Pharmaceutics. 2023. PMID: 37514056 Free PMC article.

6

Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis.

Michaličková D, Hrnčíř T, Canová NK, Slanař O. Michaličková D, et al. Among authors: slanar o. Eur J Pharmacol. 2020 Apr 15;873:172973. doi: 10.1016/j.ejphar.2020.172973. Epub 2020 Feb 1. Eur J Pharmacol. 2020. PMID: 32017935 Review.

7

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans.

Hofmann J, Bartůněk A, Hauser T, Sedmak G, Beránek J, Ryšánek P, Šíma M, Slanař O. Hofmann J, et al. Among authors: slanar o. Leukemia. 2023 Dec;37(12):2486-2492. doi: 10.1038/s41375-023-02045-1. Epub 2023 Oct 3. Leukemia. 2023. PMID: 37789147 Free PMC article.

8

Bioavailability of Orally Administered Drugs After Bariatric Surgery.

Dvořáčková E, Pilková A, Matoulek M, Slanař O, Hartinger JM. Dvořáčková E, et al. Among authors: slanar o. Curr Obes Rep. 2024 Mar;13(1):141-153. doi: 10.1007/s13679-023-00548-7. Epub 2024 Jan 3. Curr Obes Rep. 2024. PMID: 38172482 Review.

9

Explaining dissolution properties of rivaroxaban cocrystals.

Hriňová E, Skořepová E, Čerňa I, Královičová J, Kozlík P, Křížek T, Roušarová J, Ryšánek P, Šíma M, Slanař O, Šoóš M. Hriňová E, et al. Among authors: slanar o. Int J Pharm. 2022 Jun 25;622:121854. doi: 10.1016/j.ijpharm.2022.121854. Epub 2022 May 25. Int J Pharm. 2022. PMID: 35623488

10

Pathogenesis of Collagen-Induced Arthritis: Role of Immune Cells with Associated Cytokines and Antibodies, Comparison with Rheumatoid Arthritis.

Šteigerová M, Šíma M, Slanař O. Šteigerová M, et al. Among authors: slanar o. Folia Biol (Praha). 2023;69(2):41-49. doi: 10.14712/fb2023069020041. Folia Biol (Praha). 2023. PMID: 38063000 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year